JP2011088912A - チオクト酸のl−カルニチンとの塩基性塩を含む、医薬組成物および健康補助食品 - Google Patents
チオクト酸のl−カルニチンとの塩基性塩を含む、医薬組成物および健康補助食品 Download PDFInfo
- Publication number
- JP2011088912A JP2011088912A JP2010270939A JP2010270939A JP2011088912A JP 2011088912 A JP2011088912 A JP 2011088912A JP 2010270939 A JP2010270939 A JP 2010270939A JP 2010270939 A JP2010270939 A JP 2010270939A JP 2011088912 A JP2011088912 A JP 2011088912A
- Authority
- JP
- Japan
- Prior art keywords
- carnitine
- thioctic acid
- salt
- pharmaceutical composition
- quaternary ammonium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 title claims abstract description 38
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 title claims abstract description 37
- 235000019136 lipoic acid Nutrition 0.000 title claims abstract description 37
- 229960002663 thioctic acid Drugs 0.000 title claims abstract description 37
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 title claims abstract description 33
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 8
- 230000000153 supplemental effect Effects 0.000 title abstract 2
- 150000001447 alkali salts Chemical class 0.000 title description 4
- 229960001518 levocarnitine Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 claims abstract description 16
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims abstract description 9
- 125000001453 quaternary ammonium group Chemical group 0.000 claims abstract description 9
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 8
- 150000001342 alkaline earth metals Chemical class 0.000 claims abstract description 7
- 150000001340 alkali metals Chemical class 0.000 claims abstract 4
- -1 alkali metal cation Chemical class 0.000 claims description 7
- 235000015872 dietary supplement Nutrition 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 150000001768 cations Chemical class 0.000 abstract 3
- 239000000126 substance Substances 0.000 abstract 1
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 36
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 15
- 238000004821 distillation Methods 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- 239000007787 solid Substances 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- 229960004203 carnitine Drugs 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- AGBQKNBQESQNJD-ZETCQYMHSA-N (S)-lipoic acid Chemical compound OC(=O)CCCC[C@H]1CCSS1 AGBQKNBQESQNJD-ZETCQYMHSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 208000031229 Cardiomyopathies Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 230000004220 muscle function Effects 0.000 description 1
- 230000004783 oxidative metabolism Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/02—Five-membered rings
- C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Compositions Of Oxide Ceramics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Catalysts (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
Abstract
L−カルニチンとチオクト酸を、重量比及び力価にばらつきが無く組み合わせ投与をすることを課題とする。
【解決手段】
式(I)、AY(X)x、(式中、Aは式(I)であり、Yは、アルカリ金属のカチオン、アルカリ土類金属のカチオン、または第四級アンモニウム基であり、XはAまたはOH-であり、xは、Yがアルカリ金属のカチオンまたは第四級アンモニウム基の場合は0であり、かつYがアルカリ土類金属の場合は1である)を有するチオクト酸のL−カルニチンとの塩を含む医薬組成物および健康補助食品を提供する。
【選択図】 なし
Description
本発明は、チオクト酸のL−カルニチンとの新規塩を含む、医薬組成物および健康補助食品に関する。
L−カルニチンは、脂肪酸の酸化的代謝に基本的な役割を果たすミトコンドリア代謝産物である。
する医薬組成物および健康補助食品に関する。本発明はまた、上記の塩を調製する方法に関する。
本発明の目的は、式、
AY(X)x
式中、Aは
XはAまたはOH-であり、
xは、Yがアルカリ金属のカチオンまたは第四級アンモニウム基の場合は0であり、かつYがアルカリ土類金属の場合は1である、
を有する塩である。
a)10%〜30%w/vの間のL−カルニチン濃度を有する、L−カルニチンのアルカリ塩、アルカリ土類金属塩、または第四級アンモニウム塩の、直鎖または分岐C1〜C5アルコール溶液を調製し、
b)工程a)の該溶液を、75℃を超える沸点を持つケトン、75℃を超える沸点を持つエステル類、アセトニトリル、および3個より多い数の炭素原子を持つ直鎖または分岐アルコールから選択される溶媒中に、5%〜15%の間の濃度のチオクト酸を含む溶液にゆっくりと加え、そして
c)式(I)の塩を単離する、工程を含む、上記塩を調製する方法である。
i)L−カルニチンを溶解させた溶媒が、減圧蒸留により一部除去され、
ii)チオクト酸を溶解させた同一溶媒が、好ましくは工程i)で除去した溶媒と置き換えるのに必要な量で、加えられ、
iii)混合物が、0℃〜30℃の間の温度に冷却され、そして完全に沈殿するまで撹拌下に置かれ、そして
iv)得られた沈殿が分離される、操作段階を含む。
δNMR:
4.51ppm、1H、m(−CH−(OH)−、カルニチン);3.68ppm、1H
、m(−CH−(S)−、チオクト酸);3.38ppm、2H、m(−N−(CH3)3−CH2、カルニチン)3.18ppm、2H、m(チオクト酸環の2位にあるメチレン)3.18ppm、9H、s(−N−(CH3)3−CH2−、カルニチン);2.45ppm、1H、m(チオクト酸環の3位にある2個の水素原子のうちの1つ);2.39ppm、2H、dd(−CH2−COO-、カルニチン);2.14ppm、2H、t(CH2−(COOH)チオクト酸);1.96ppm、1H、m(チオクト酸環の3位にある2個の水素原子のうちの1つ)、1.3〜1.8ppm、6H、m(−CH2−CH2−CH2−、チオクト酸)。
以下のピークが観測される:
206(m/e):チオクト酸の分子ピーク
161(m/e):カルニチンの分子ピーク
全に溶解するまで、20℃〜25℃の温度で攪拌する。粘稠または油状の黄色残渣(52g)が得られるまで、減圧下40℃未満の温度で、溶媒を蒸留して除去する。完全な溶液が得られるようにすることなく、残渣を200mlの水で戻す;巨大な粘着性の凝集体(チオクト酸の重合体)が溶液中に分離する。
Claims (2)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2003A000831 | 2003-04-22 | ||
IT000831A ITMI20030831A1 (it) | 2003-04-22 | 2003-04-22 | Sale basico dell'acido tiottico con la l-carnitina. |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004571034A Division JP4688502B2 (ja) | 2003-04-22 | 2003-10-31 | チオクト酸のl−カルニチンとの塩基性塩 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2011088912A true JP2011088912A (ja) | 2011-05-06 |
JP5220087B2 JP5220087B2 (ja) | 2013-06-26 |
Family
ID=33187379
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004571034A Expired - Fee Related JP4688502B2 (ja) | 2003-04-22 | 2003-10-31 | チオクト酸のl−カルニチンとの塩基性塩 |
JP2010270939A Expired - Fee Related JP5220087B2 (ja) | 2003-04-22 | 2010-12-03 | チオクト酸のl−カルニチンとの塩基性塩を含む、医薬組成物および健康補助食品 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004571034A Expired - Fee Related JP4688502B2 (ja) | 2003-04-22 | 2003-10-31 | チオクト酸のl−カルニチンとの塩基性塩 |
Country Status (15)
Country | Link |
---|---|
US (1) | US7235582B2 (ja) |
EP (1) | EP1615908B1 (ja) |
JP (2) | JP4688502B2 (ja) |
KR (1) | KR101093866B1 (ja) |
CN (1) | CN100567287C (ja) |
AT (1) | ATE374764T1 (ja) |
AU (1) | AU2003276231A1 (ja) |
CY (1) | CY1107834T1 (ja) |
DE (1) | DE60316732T2 (ja) |
DK (1) | DK1615908T3 (ja) |
ES (1) | ES2295705T3 (ja) |
IT (1) | ITMI20030831A1 (ja) |
PT (1) | PT1615908E (ja) |
SI (1) | SI1615908T1 (ja) |
WO (1) | WO2004094403A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4951226B2 (ja) * | 2005-09-08 | 2012-06-13 | 立山化成株式会社 | α−リポ酸アルカリ塩の製法 |
ITMI20061024A1 (it) | 2006-05-25 | 2007-11-26 | Eurand Pharmaceuticals Ltd | Pellet a base di acido lipoico |
KR100903549B1 (ko) * | 2008-07-29 | 2009-06-23 | 주식회사 카이로제닉스 | 균질한 결정성의 아세틸-l-카르니틴과 티옥트산 칼륨염의 복합염, 이의 제조방법 및 이를 포함하는 약학적 조성물 |
KR100935554B1 (ko) | 2009-06-24 | 2010-01-07 | 주식회사 셀트리온제약 | 피페라진 다이티옥트산염 및 이를 포함하는 약제학적 조성물 |
NZ763699A (en) * | 2017-11-17 | 2022-05-27 | Cellix Bio Private Ltd | Compounds, compositions and methods for treatment of eye disorders and skin diseases |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001508804A (ja) * | 1997-06-16 | 2001-07-03 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 代謝を増強し酸化ストレスを防止するための食物組成物 |
US6479069B1 (en) * | 1999-09-23 | 2002-11-12 | Juvenon, Inc. | Nutritional supplement for increased energy and stamina |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR4512E (fr) | 1904-07-12 | 1905-08-26 | Georges Albert Simon Weill | Genre de lyre de construction économique pour suspensions de lampes |
DE19653908A1 (de) * | 1996-12-21 | 1998-06-25 | Daimler Benz Ag | Einrichtung zum Anschluß eines Rohrkrümmers |
DE19818563C2 (de) * | 1998-04-25 | 2003-04-17 | Sueddeutsche Kalkstickstoff | Verwendung von alpha-Liponsäure zur Verringerung des Appetits und/oder zur Körpergewichtsreduzierung |
AU1176500A (en) * | 1998-11-11 | 2000-05-29 | Manabu Nomura | Health-promoting foods |
JP4824152B2 (ja) * | 2000-04-28 | 2011-11-30 | 太陽化学株式会社 | 血流改善剤 |
DE10022856A1 (de) * | 2000-05-10 | 2001-11-15 | Basf Ag | Therapeutische Kombination von Liponsäure und C1-Donoren zur Behandlung von Störungen des Zentralen Nervensystems |
WO2002017735A2 (de) * | 2000-08-29 | 2002-03-07 | Lonza Ag | Verfahren zur herstellung einer granulierbaren mischung und carnitin-magnesium-hydroxycitrat |
JP4672124B2 (ja) * | 2000-09-14 | 2011-04-20 | 丸善製薬株式会社 | テストステロン5α−レダクターゼ阻害剤及びアンドロゲン受容体結合阻害剤、抗男性ホルモン剤、養毛化粧料、前立腺肥大抑制剤並びに健康補助食品 |
IT1319196B1 (it) | 2000-10-10 | 2003-09-26 | Laboratorio Chimico Int Spa | Sintesi dell'acido r(+)alfa-lipoico. |
IT1319194B1 (it) | 2000-10-10 | 2003-09-26 | Laboratorio Chimico Int Spa | Processo per la produzione dell'acido tiottico racemo. |
IT1319195B1 (it) | 2000-10-10 | 2003-09-26 | Laboratorio Chimico Int Spa | Processo per la produzione dell'acido r(+)alfa-lipoico. |
JP2002171934A (ja) * | 2000-12-05 | 2002-06-18 | Takahisa Shioda | タマネギの薄皮(表皮)を原材料とする健康補助食品の製造方法。 |
WO2002052956A1 (fr) * | 2000-12-27 | 2002-07-11 | The Nisshin Oillio, Ltd. | Boisson ou aliment antitumoral |
JP4953512B2 (ja) * | 2001-02-13 | 2012-06-13 | 丸善製薬株式会社 | テストステロン5α−レダクターゼ阻害剤、アンドロゲン受容体結合阻害剤、抗男性ホルモン剤、頭髪化粧料、前立腺肥大抑制剤 |
JPWO2002078468A1 (ja) * | 2001-03-30 | 2004-08-19 | 日清オイリオ株式会社 | 血管障害疾患用飲食物 |
-
2003
- 2003-04-22 IT IT000831A patent/ITMI20030831A1/it unknown
- 2003-10-31 AT AT03816670T patent/ATE374764T1/de active
- 2003-10-31 WO PCT/EP2003/012179 patent/WO2004094403A1/en active IP Right Grant
- 2003-10-31 ES ES03816670T patent/ES2295705T3/es not_active Expired - Lifetime
- 2003-10-31 PT PT03816670T patent/PT1615908E/pt unknown
- 2003-10-31 CN CNB2003801040307A patent/CN100567287C/zh not_active Expired - Fee Related
- 2003-10-31 EP EP03816670A patent/EP1615908B1/en not_active Expired - Lifetime
- 2003-10-31 SI SI200331066T patent/SI1615908T1/sl unknown
- 2003-10-31 AU AU2003276231A patent/AU2003276231A1/en not_active Abandoned
- 2003-10-31 DK DK03816670T patent/DK1615908T3/da active
- 2003-10-31 JP JP2004571034A patent/JP4688502B2/ja not_active Expired - Fee Related
- 2003-10-31 DE DE60316732T patent/DE60316732T2/de not_active Expired - Lifetime
- 2003-10-31 KR KR1020057008064A patent/KR101093866B1/ko not_active IP Right Cessation
- 2003-11-03 US US10/698,451 patent/US7235582B2/en not_active Expired - Fee Related
-
2007
- 2007-12-14 CY CY20071101594T patent/CY1107834T1/el unknown
-
2010
- 2010-12-03 JP JP2010270939A patent/JP5220087B2/ja not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001508804A (ja) * | 1997-06-16 | 2001-07-03 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 代謝を増強し酸化ストレスを防止するための食物組成物 |
US6479069B1 (en) * | 1999-09-23 | 2002-11-12 | Juvenon, Inc. | Nutritional supplement for increased energy and stamina |
Non-Patent Citations (2)
Title |
---|
JPN6010009990; LIU, J., et al.: Proc. Natl. Acad. Sci. USA 99(4), pp.2356-2361 (2002) * |
JPN6010009991; HAGEN, T.M., et al.: Proc. Natl. Acad. Sci. USA 99(4), pp.1870-1875 (2002) * |
Also Published As
Publication number | Publication date |
---|---|
DK1615908T3 (da) | 2008-02-04 |
AU2003276231A1 (en) | 2004-11-19 |
EP1615908B1 (en) | 2007-10-03 |
CN1714088A (zh) | 2005-12-28 |
DE60316732T2 (de) | 2008-07-17 |
CN100567287C (zh) | 2009-12-09 |
JP4688502B2 (ja) | 2011-05-25 |
US20040214879A1 (en) | 2004-10-28 |
SI1615908T1 (sl) | 2008-02-29 |
JP2006515314A (ja) | 2006-05-25 |
ATE374764T1 (de) | 2007-10-15 |
JP5220087B2 (ja) | 2013-06-26 |
WO2004094403A1 (en) | 2004-11-04 |
PT1615908E (pt) | 2008-01-10 |
KR101093866B1 (ko) | 2011-12-13 |
ITMI20030831A1 (it) | 2004-10-23 |
DE60316732D1 (en) | 2007-11-15 |
US7235582B2 (en) | 2007-06-26 |
KR20060011936A (ko) | 2006-02-06 |
ES2295705T3 (es) | 2008-04-16 |
CY1107834T1 (el) | 2013-06-19 |
EP1615908A1 (en) | 2006-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5220087B2 (ja) | チオクト酸のl−カルニチンとの塩基性塩を含む、医薬組成物および健康補助食品 | |
CN102459142B (zh) | 用于治疗与心血管、代谢和炎性疾病领域相关的疾病的多不饱和脂肪酸 | |
KR102405650B1 (ko) | 트레프로스티닐의 염 | |
EP0415850A1 (fr) | Sels de métaux bivalents de l'acide N, N-di(carboxyméthyl)amino-2 cyano-3 carboxyméthyl-4 carboxy-5 thiophène,leur procédé de préparation et les compositions pharmaceutiques les renfermant | |
US8278478B2 (en) | Process for the synthesis of hydrochloride salt of N-fatty acylsubstituted amino acid ethyl esters | |
EP3388424A1 (en) | Method for preparing anti-heart-failure medicine lcz696 | |
CZ293282B6 (cs) | Kreatinpyruvát, způsob jeho výroby a kompozice s jeho obsahem | |
CN1092194C (zh) | 二氨基嘧啶,含它们的药物组合物和其作为抗菌药物的用途 | |
CA2100868C (en) | Derivatives of dicarboxylic acids having six to twelve carbon atoms and use of these derivatives and dicarboxylic acids alone in the preparation of pharmaceutical compositions forenteral and parenteral nutrition | |
CN104140384B (zh) | 一种分步结晶制备硫代烷基/链烯基半胱氨酸亚砜的方法 | |
JP2006265202A (ja) | α−リポ酸アミノ酸塩 | |
US7649103B2 (en) | Long chain unsaturated oxygenated compounds and their use in the therapeutical, cosmetic and nutraceutical field | |
JPH0278675A (ja) | ベンゾフラニル酢酸誘導体、その製法、粘液調節剤および抗ヒスタミン剤 | |
BRPI0702865A2 (pt) | processos para preparaÇço do Ácido 3-isobutilglutÁrico e de (s)- pregabalin, a partir de combinaÇÕes de composiÇÕes com fàrmulas especÍficas para uso na dita preparaÇço | |
JP2014189542A (ja) | アミド誘導体の製造方法 | |
KR102552918B1 (ko) | 신규한 오르트산염 중간체를 이용한 카르니틴 오르트산염의 제조방법 | |
EP1196371B1 (fr) | Precurseurs de sels de bis-ammonium quaternaire et leurs applications comme prodrogues ayant une activite anti-parasitaire | |
JPS5912118B2 (ja) | 対称ヒドロキシ−チオアルカンの製造方法 | |
JP2000510486A (ja) | α−トコフェロール−4−アミノ安息香酸エステル化合物及びその製造方法 | |
KR20190048400A (ko) | 해열, 진통 및 소염 활성을 갖는 에스테르 및 산무수물 및 이의 제조방법 | |
US20070027110A1 (en) | Double salts of (-)-hydroxycitric acid with an amine and a group II a metal and a process for preparing the same | |
JP2011068563A (ja) | カルニチンフマル酸塩及びその製造方法 | |
JPWO2021076847A5 (ja) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130212 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130305 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160315 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5220087 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |